OOIR: Observatory of International Research

Papers

(The TQCC of Gut Pathogens is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Gut microbiota influence in type 2 diabetes mellitus (T2DM)	127
Designing a novel multi-epitope vaccine to evoke a robust immune response against pathogenic multidrug-resistant Enterococcus faecium bacterium	71
Eubacterium rectale contributes to colorectal cancer initiation via promoting colitis	64
In silico molecular docking and in vitro antimicrobial efficacy of phytochemicals against multi-drug-resistant enteroaggregative Escherichia coli and non-typhoidal Salmonella spp.	40
The use of biomarkers associated with leaky gut as a diagnostic tool for early intervention in autism spectrum disorder: a systematic review	38
Interplay between severities of COVID-19 and the gut microbiome: implications of bacterial co-infections?	33
Association of small intestinal bacterial overgrowth with Parkinson’s disease: a systematic review and meta-analysis	32
Ectopic gut colonization: a metagenomic study of the oral and gut microbiome in Crohn’s disease	31
Role of interferon gamma in SARS-CoV-2-positive patients with parasitic infections	31
Emergence of plasmid-mediated mcr genes from Gram-negative bacteria at the human-animal interface	27
The gut metagenomics and metabolomics signature in patients with inflammatory bowel disease	27
Gut microbiota of patients with different subtypes of gastric cancer and gastrointestinal stromal tumors	26
Bacteroides, butyric acid and t10,c12-CLA changes in colorectal adenomatous polyp patients	22
Antimicrobial resistance patterns and genetic elements associated with the antibiotic resistance of Helicobacter pylori strains from Shanghai	21
Antibiotic resistance and detection of plasmid mediated colistin resistance mcr-1 gene among Escherichia coli and Klebsiella pneumoniae isolated from clinical samples	20
Impact of azithromycin mass drug administration on the antibiotic-resistant gut microbiome in children: a randomized, controlled trial	20
Prevalence, antimicrobial resistance, and genotyping of Shiga toxin-producing Escherichia coli in foods of cattle origin, diarrheic cattle, and diarrheic humans in Egypt	20
Relationship between gut microbiome diversity and hepatitis B viral load in patients with chronic hepatitis B	20
Exosomal CagA from Helicobacter pylori aggravates intestinal epithelium barrier dysfunction in chronic colitis by facilitating Claudin-2 expression	19
Gut microbiota in the early stage of Crohn’s disease has unique characteristics	19
Virulence among different types of hypervirulent Klebsiella pneumoniae with multi-locus sequence type (MLST)-11, Serotype K1 or K2 strains	18
Prevalence, antimicrobial susceptibility and virulence gene profiles of Arcobacter species isolated from human stool samples, foods of animal origin, ready-to-eat salad mixes and environmental water	18
The emerging role of neutrophilic extracellular traps in intestinal disease	18
Emerging role of bacterial outer membrane vesicle in gastrointestinal tract	17
Assessing the impact of storage time on the stability of stool microbiota richness, diversity, and composition	17

Hepatitis D: challenges in the estimation of true prevalence and laboratory diagnosis	17
Clinical manifestations, risk factors, and prognostic factors of cytomegalovirus enteritis	17
Geographic distribution of the cagA, vacA, iceA, oipA and dupA genes of Helicobacter pylori strains isolated in China	17
Transcriptional regulation of the virulence genes and the biofilm formation associated operons in Vibrio parahaemolyticus	17
Prevalence of pks + bacteria and enterotoxigenic Bacteroides fragilis in patients with colorectal cancer	17
Effect of crude polysaccharide from seaweed, Dictyopteris divaricata (CDDP) on gut microbiota restoration and anti-diabetic activity in streptozotocin (STZ)-induced T1DM mice	16
Gut microbiota imbalance in colorectal cancer patients, the risk factor of COVID-19 mortality	16
Emerging applications of phage therapy and fecal virome transplantation for treatment of Clostridioides difficile infection: challenges and perspectives	15
Proton pump inhibitors use and risk of developing spontaneous bacterial peritonitis in cirrhotic patients: A systematic review and meta-analysis	15
Influence of lincomycin-spectinomycin treatment on the outcome of Enterococcus cecorum infection and on the cecal microbiota in broilers	14
Effect of probiotic supplementation on gastrointestinal motility, inflammation, motor, non-motor symptoms and mental health in Parkinson’s disease: a meta-analysis of randomized controlled trials	14
The genomic characterisation and comparison of Bacillus cereus strains isolated from indoor air	13
Changing serotypes of hand, foot and mouth disease in Shanghai, 2017–2019	13
Impact of Helicobacter pylori eradication on the gastric microbiome	13
Detection of SARS-CoV-2 from patient fecal samples by whole genome sequencing	13
Enterotoxigenic Bacteroides fragilis activates IL-8 expression through Stat3 in colorectal cancer cells	12
Presence of plasmid-mediated quinolone resistance (PMQR) genes in non-typhoidal Salmonella strains with reduced susceptibility to fluoroquinolones isolated from human salmonellosis in Gyeonggi-do, Sou	12
Potential capacity of interferon-α to eliminate covalently closed circular DNA (cccDNA) in hepatocytes infected with hepatitis B virus	12
The role of mycobiota-genotype association in inflammatory bowel diseases: a narrative review	11
Deepoxy-deoxynivalenol (DOM-1), a derivate of deoxynivalenol (DON), exhibits less toxicity on intestinal barrier function, Campylobacter jejuni colonization and translocation in broiler chickens	11
Improved gut microbiota features after the resolution of SARS‑CoV‑2 infection	11
A prospective investigation into the association between the gut microbiome composition and cognitive performance among healthy young adults	10
Genomic patterns and characterizations of chromosomally-encoded mcr-1 in Escherichia coli populations	10
Microbiome profiling of rotavirus infected children suffering from acute gastroenteritis	10
Mixtures of natural antimicrobials can reduce Campylobacter jejuni, Salmonella enterica and Clostridium perfringens infections and cellular inflammatory response in MDCK cells	10
Gut microbiota signatures and fecal metabolites in postmenopausal women with osteoporosis	9
Adherent invasive Escherichia coli (AIEC) strain LF82, but not Candida albicans, plays a profibrogenic role in the intestine	9
Microbiota profile of new-onset celiac disease in children in Saudi Arabia	9
Role of fecal calprotectin as a hypoxic intestinal damage biomarker in COVID-19 patients	9
A re-testing range is recommended for 13C- and 14C-urea breath tests for Helicobacter pylori infection in China	9
The interactions of Candida albicans with gut bacteria: a new strategy to prevent and treat invasive intestinal candidiasis	9
Recent five-year progress in the impact of gut microbiota on vaccination and possible mechanisms	9
Grape seed and skin extract, a potential prebiotic with anti-obesity effect through gut microbiota modulation	9
Comparison of antimicrobial resistant Escherichia coli isolated from Irish commercial pig farms with and without zinc oxide and antimicrobial usage	9
Differences in epidemiology of enteropathogens in children pre- and post-rotavirus vaccine introduction in Kilifi, coastal Kenya	9
Analysis of gastric microbiota and Helicobacter pylori infection in gastroesophageal reflux disease	9
The endemic Helicobacter pylori population in Southern Vietnam has both South East Asian and European origins	8
Fusobacterium nucleatum promotes the development of acute liver failure by inhibiting the NAD+ salvage metabolic pathway	8
High genetic diversity in Campylobacter concisus isolates from patients with microscopic colitis	8
The penicillin binding protein 1A of Helicobacter pylori, its amoxicillin binding site and access routes	8
Effect of proton pump inhibitors in infants with esophageal atresia on the gut microbiome: a pilot cohort	8
The role of non-Helicobacter pylori bacteria in the pathogenesis of gastroduodenal diseases	8
The glycosyltransferase ST3GAL2 is regulated by miR-615-3p in the intestinal tract of Campylobacter jejuni infected mice	8
Comparative genomics of Helicobacter pullorum from different countries	8
Insights about the epidemiology of Salmonella Typhimurium isolates from different sources in Brazil using comparative genomics	8
The effect of Campylobacter jejuni and Campylobacter coli colonization on the gut morphology, functional integrity, and microbiota composition of female turkeys	8
Production of highly immunogenic and safe Triton X-100 produced bacterial ghost vaccine against Shigella flexneri 2b serotype	8